Martínez-Sánchez C, Jerjes-Sánchez C, Nicolau JC, et al. Acute coronary syndromes in Latin America: lessons from the ACCESS registry. Rev Med Inst Mex Seguro Soc 2016; 54: 726−737.
[10] Maier Gde S, Martins EA. Health care for patients with acute coronary syndrome according to quality indicators. Rev Bras Enferm 2016; 69: 757−764. doi: 10.1590/0034-7167.2016690420i [11] Rodríguez-Ramos MA. Increasing quality of secondary prevention of acute myocardial infarction by using E-health. High Blood Press Cardiovasc Prev 2019; 26: 81−82. doi: 10.1007/s40292-018-0294-8 [12] Arora S, Stouffer GA, Kucharska-Newton AM, et al. Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction: The ARIC Community Surveillance Study. Circulation 2019; 139: 1047−1056. doi: 10.1161/CIRCULATIONAHA.118.037137 [13] Wittlinger T, Seifert C, Simonis G, et al. Prognosis in myocardial infarction of young patients: Results of a prospective registry. Int J Cardiol 2020; 300: 1−6. doi: 10.1016/j.ijcard.2019.10.037 [14]Fu R, Li SD, Song CX, et al. Clinical significance of diabetes on symptom and patient delay among patients with acute myocardial infarction-an analysis from China Acute Myocardial Infarction (CAMI) registry. J Geriatr Cardiol 2019; 16: 395−400.
[15] Jimenez-Quevedo P, Brugaletta S, Cequier A, et al. Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial. Catheter Cardiovasc Interv 2019; 94: 917−925. doi: 10.1002/ccd.28194 [16] Jollis JG, Al-Khalidi HR, Roettig ML, et al. Impact of regionalization of ST-segment-elevation myocardial infarction care on treatment times and outcomes for emergency medical services-transported patients presenting to hospitals with percutaneous coronary intervention: mission: lifeline accelerator-2. Circulation 2018; 137: 376−387. doi: 10.1161/CIRCULATIONAHA.117.032446 [17] Puymirat E, Cayla G, Cottin Y, et al. Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995–2015. Am Heart J 2019; 214: 97−106. doi: 10.1016/j.ahj.2019.05.007 [18] Aliprandi-Costa B, Morgan L, Snell LC, et al. ST-elevation acute myocardial infarction in australia-temporal trends in patient management and outcomes 1999–2016. Heart Lung Circ 2019; 28: 1000−1008. doi: 10.1016/j.hlc.2018.05.191 [19]León-Aliz E, Moreno-Martínez FL, Pérez-Fernández GA, et al. Índice leuco-glucémico como marcador pronóstico de la evolución intrahospitalaria en pacientes con infarto agudo de miocardio con elevación del ST. Clin Invest Arterioscl 2014; 26: 168−175.
[20]Iraola M, Ordúñez P, Alvarez F, et al. Unidad de cuidados intensivos cardiológicos: impacto sobre la mortalidad por infarto agudo del miocardio. Mejora continua de la calidad. MOI 2002; 2: 23.
[21] [22]González-Rodríguez R, Carrillo-Blanco Y, Barcón-Díaz L, et al. Effectiveness of thrombolysis in acute myocardial infarction at Abel Santamaria Cuadrado General Teaching Hospital. Rev Ciencias Médicas Marzo-abril 2019; 23: 224−231.
[23] Robichaud L, Ross D, Proulx MH, et al. Prehospital Nitroglycerin Safety in Inferior ST Elevation Myocardial Infarction. Prehosp Emerg Care 2016; 20: 76−81. doi: 10.3109/10903127.2015.1037480 [24] Bosson N, Isakson B, Morgan JA, et al. Safety and effectiveness of field nitroglycerin in patients with suspected ST elevation myocardial infarction. Prehosp Emerg Care 2019; 23: 603−611. doi: 10.1080/10903127.2018.1558318 [25]Zeitouni M, Kerneis M, Lattuca B, et al. Do patients need lifelong β-blockers after an uncomplicated myocardial infarction? Am J Cardiovasc Drugs 2019; 19: 431−438.
[26] Dahl Aarvik M, Sandven I, Dondo TB, et al. Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother 2019; 5: 12−20. doi: 10.1093/ehjcvp/pvy034 [27] Chung J, Han JK, Kim YJ, et al. Benefit of vasodilating β-blockers in patients with acute myocardial infarction after percutaneous coronary intervention: nationwide multicenter cohort study. J Am Heart Assoc 2017; 6: e007063. doi: 10.1161/JAHA.117.007063 [28]Ariza-Solé A, Alegre O, Elola FJ, et al. Management of myocardial infarction in the elderly. Insights from Spanish Minimum Basic Data Set. Eur Heart J Acute Cardiovasc Care 2019; 8: 242−251.
[29]Balk M, Gomes HB, Quadros AS, et al. Comparative analysis between transferred and self-referred STEMI patients undergoing primary angioplasty. Arq Bras Cardiol 2019; 112: 402−407.
[30] Roule V, Ardouin P, Blanchart K, et al. Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Crit Care 2016; 20: 359. doi: 10.1186/s13054-016-1530-z
留言 (0)